G. Harb

Comparison of quality of life, work productivity and medical resource utilization of peginterferon alpha 2a <i>vs</i> the combination of interferon alpha 2b plus ribavirin as initial treatment in patients with chronic hepatitis C

Robert Perrillo, Kenneth D. Rothstein, Raymond A. Rubin et al. · Journal of Viral Hepatitis · 2004 · 50 citations

Pharmacy, Internal Medicine, Pharmacotherapy +17

Central venous catheter infections in AIDS patients receiving treatment for cytomegalovirus disease.

Hopkins Stanley, Edwin D. Charlebois, G. Harb et al. · PubMed · 1994 · 36 citations

Veterinary Medicine, Infectious Diseases, Internal Medicine +13

[516] A RANDOMIZED TRIAL OF SWITCHING TO TELBIVUDINE VERSUS CONTINUED LAMIVUDINE IN ADULTS WITH CHRONIC HEPATITIS B: RESULTS OF THE PRIMARY ANALYSIS AT WEEK 24

Rifaat Safadi, Qianling Xie, Y. Chen et al. · Journal of Hepatology · 2007 · 14 citations

Pharmacy, Pharmacology, Pharmacotherapy +9

332 Peginterferon alfa-2A (40KD) (PEGASYS®) in combination with ribavirin in African American and Caucasian patients with chronic hepatitis C HCV genotype 1: safety and tolerability

Charles D. Howell, L. Jeffers, William M. Cassidy et al. · Hepatology · 2003 · 11 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17